1. Home
  2. NBIX vs CLH Comparison

NBIX vs CLH Comparison

Compare NBIX & CLH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBIX
  • CLH
  • Stock Information
  • Founded
  • NBIX 1992
  • CLH 1980
  • Country
  • NBIX United States
  • CLH United States
  • Employees
  • NBIX 1448
  • CLH N/A
  • Industry
  • NBIX Biotechnology: Biological Products (No Diagnostic Substances)
  • CLH Environmental Services
  • Sector
  • NBIX Health Care
  • CLH Industrials
  • Exchange
  • NBIX Nasdaq
  • CLH Nasdaq
  • Market Cap
  • NBIX 11.8B
  • CLH 13.9B
  • IPO Year
  • NBIX 1996
  • CLH 1987
  • Fundamental
  • Price
  • NBIX $117.44
  • CLH $247.39
  • Analyst Decision
  • NBIX Buy
  • CLH Strong Buy
  • Analyst Count
  • NBIX 24
  • CLH 9
  • Target Price
  • NBIX $163.91
  • CLH $258.11
  • AVG Volume (30 Days)
  • NBIX 1.0M
  • CLH 382.5K
  • Earning Date
  • NBIX 10-30-2024
  • CLH 10-30-2024
  • Dividend Yield
  • NBIX N/A
  • CLH N/A
  • EPS Growth
  • NBIX 97.40
  • CLH 15.34
  • EPS
  • NBIX 3.73
  • CLH 7.68
  • Revenue
  • NBIX $2,242,800,000.00
  • CLH $5,797,005,000.00
  • Revenue This Year
  • NBIX $26.97
  • CLH $10.09
  • Revenue Next Year
  • NBIX $16.69
  • CLH $6.01
  • P/E Ratio
  • NBIX $31.50
  • CLH $32.21
  • Revenue Growth
  • NBIX 25.72
  • CLH 8.37
  • 52 Week Low
  • NBIX $108.14
  • CLH $158.42
  • 52 Week High
  • NBIX $157.98
  • CLH $267.11
  • Technical
  • Relative Strength Index (RSI)
  • NBIX 42.69
  • CLH 46.16
  • Support Level
  • NBIX $119.08
  • CLH $220.10
  • Resistance Level
  • NBIX $129.67
  • CLH $265.72
  • Average True Range (ATR)
  • NBIX 3.34
  • CLH 7.60
  • MACD
  • NBIX -0.02
  • CLH -0.05
  • Stochastic Oscillator
  • NBIX 14.59
  • CLH 58.05

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

About CLH Clean Harbors Inc.

Clean Harbors Inc is an environmental and industrial services provider. It provides parts cleaning and related environmental services to commercial, industrial, and automotive customers. Its business segments are Environmental Services and Safety-Kleen Sustainability Solutions. The company generates the majority of its revenues from the Environmental Services segment.

Share on Social Networks: